Real-world experience with a Paclitaxel-Coated Balloon for the treatment of atherosclerotic infrainguinal arteries: 12-month interim results of the BIOLUX P-III registry first year of enrolment.

ABSTRACT:

Background

Endovascular management of atherosclerotic infrainguinal arteries recently shifted towards drug eluting devices, designed to locally prevent the restenosis process. Numerous clinical studies report an advantage of drug coated balloons over uncoated balloon angioplasty in treating lower extremity peripheral artery disease. However, as coating and balloon platforms are different, each device requires dedicated clinical evaluations.

Objective

The aim of the study is to further investigate the safety and effectiveness of a Paclitaxel-Coated Balloon for the treatment of atherosclerotic infrainguinal arteries in a real-world setting.

Methods

203 patients out of a final sample of 882 were enrolled in this prospective multicenter, observational, all-comers registry

SUBMITTER: Brodmann M 

PROVIDER: S-EPMC5944304 | biostudies-literature | 2017 Oct-Dec

REPOSITORIES: biostudies-literature